KLRS

Kalaris Therapeutics
KLRS

Overview Fund Trends Analyst Outlook Journalist POV

59 hedge funds and large institutions have $36.3M invested in Kalaris Therapeutics in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 31 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

86% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 14

Holders
59
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$26K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.13M
2
+$68.6K
3
+$36K
4
Osaic Holdings
Osaic Holdings
Arizona
+$3K
5
Bank of America
Bank of America
North Carolina
+$1.45K

Top Sellers

1
-$4.77M
2
-$768K
3
-$232K
4
Northern Trust
Northern Trust
Illinois
-$225K
5
Goldman Sachs
Goldman Sachs
New York
-$157K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$1.88K
52
$1.8K
53
$1.76K
54
$1K
55
$926
56
$800
57
$697
58
$562
59
$365
60
$6
61
–
62
–
63
–
64
–
65
–
66
–
67
–
68
–
69
–
70
–
71
–
72
–
73
–
1 2
3